Works by Tanase, Ana-Maria


Results: 17
    1
    2
    3
    4
    5

    Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.

    Published in:
    American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 4, p. 417, doi. 10.1164/rccm.202303-0458OC
    By:
    • Martinez, Fernando J.;
    • Criner, Gerard J.;
    • Gessner, Christian;
    • Jandl, Margret;
    • Scherbovsky, Fernando;
    • Shinkai, Masaharu;
    • Siler, Thomas M.;
    • Vogelmeier, Claus F.;
    • Voves, Robert;
    • Wedzicha, Jadwiga A.;
    • Bartels, Christian;
    • Bottoli, Ivan;
    • Byiers, Stuart;
    • Cardenas, Pamela;
    • Eckert, Joerg H.;
    • Gutzwiller, Florian S.;
    • Knorr, Barbara;
    • Kothari, Mahavir;
    • Parlikar, Rutvick;
    • Tanase, Ana-Maria
    Publication type:
    Article
    6

    Halotolerant Black Sea bacteria for bioplastics production.

    Published in:
    Studia Universitatis Babeş-Bolyai, Biologia, 2019, v. 64, n. 1, p. 119
    By:
    • Chiciudean, Iulia;
    • Mereuță, Ioana;
    • Mihalachi, Elena Luiza;
    • Lascu, Irina;
    • Avramescu, Sorin Marius;
    • Jablonski, Piotr;
    • Christensen, Mikkel;
    • Hansen, Hilde;
    • Stoica, Ileana;
    • Tănase, Ana-Maria
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study

    Published in:
    International Journal of COPD, 2018, v. 13, p. 3923, doi. 10.2147/COPD.S179293
    By:
    • Beeh, Kai Michael;
    • Kirsten, Anne-Marie;
    • Tanase, Ana-Maria;
    • Richard, Alexia;
    • Cao, Weihua;
    • Hederer, Bettina;
    • Beier, Jutta;
    • Kornmann, Oliver;
    • Zyl-Smit, Richard N van
    Publication type:
    Article
    16

    Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.

    Published in:
    Journal of Asthma & Allergy, 2023, v. 16, p. 123, doi. 10.2147/JAA.S392975
    By:
    • van Zyl-Smit, Richard N;
    • Chapman, Kenneth R;
    • Kerstjens, Huib AM;
    • Gessner, Christian;
    • Sagara, Hironori;
    • Tanase, Ana-Maria;
    • Hosoe, Motoi;
    • Pethe, Abhijit;
    • Lawrence, David;
    • Tillmann, Hanns-Christian;
    • D'Andrea, Peter
    Publication type:
    Article
    17

    Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies

    Published in:
    Journal of Asthma, 2023, v. 60, n. 2, p. 403, doi. 10.1080/02770903.2022.2056048
    By:
    • Sagara, Hironori;
    • D'Andrea, Peter;
    • Tanase, Ana-Maria;
    • Pethe, Abhijit;
    • Tanaka, Yukina;
    • Matsuo, Kazutaka;
    • Hosoe, Motoi;
    • Nakamura, Yoichi
    Publication type:
    Article